Daniel Barenboim, Parkinson's disease

Conductor Daniel Barenboim says he's been diagnosed with Parkinson's disease
Conductor Daniel Barenboim says he has been diagnosed with Parkinson’s disease. The 82-year-old issued a statement Thursday on Instagram. He has appeared more frail since 2022, canceling scheduled performances that included a new production of Wagner’s Ring Cycle in Berlin.
Conductor Daniel Barenboim reveals his Parkinson's disease diagnosis
The maestro has appeared more frail since 2022, canceling scheduled performances that included a new production of Wagner's Ring Cycle in Berlin.
Daniel Barenboim Announces He Has Parkinson’s Disease
Daniel Barenboim, the eminent conductor and pianist who stepped back from engagements in recent years citing health concerns, said Thursday that he has Parkinson’s disease.
Conductor Daniel Barenboim announces Parkinson's diagnosis
In a statement, the 81-year-old conductor stated his passion for music remains 'unchanged'
Early-onset Parkinson’s disease: Woman diagnosed at 27 reveals the warning signs
She was happily married, pregnant with her first child and had recently completed her residency in family medicine. Soon after starting work at a private practice, she noticed a slight tremor in her right pinkie finger.
Conductor Barenboim reveals Parkinson's diagnosis
The renowned musician says he plans to keep playing, after confirming the long-suspected diagnosis.
Medscape6h
Despite Early Promise GLP-1 Disappoints in Parkinson’s Disease
Exenatide had no disease-modifying effects in a phase 3 trial Parkinson’s disease, despite earlier evidence from a phase 2 ...
MedPage Today2d
FDA OKs New Wearable Treatment for Parkinson's Disease
The FDA approved an apomorphine hydrochloride infusion device (Onapgo) to treat motor fluctuations in adults with advanced ...
Ozempic-like drug fails to treat Parkinson's disease in new study; here's what the scientists said
Semaglutide, the drug used in Ozempic, has been linked to lowering the risk of Alzheimer's disease in the past. So, it was ...
Diabetes drug similar to Ozempic showed no benefits for patients with Parkinson’s disease
A drug for treating diabetes similar to popular weight-loss medicines such as Ozempic did not show any benefits for people ...
FDA approves wearable infusion device for advanced Parkinson disease
The U.S. Food and Drug Administration has approved Onapgo (apomorphine hydrochloride) injection as the first and only ...
Healio1d
GLP-1 does not slow Parkinson’s disease progression in phase 3 study
Treatment with exenatide, a GLP-1 receptor agonist, was comparable to placebo in slowing the rate of Parkinson’s disease ...
Rolling Out7d
A breakthrough in Parkinson’s disease detection
AI-powered blood test detects Parkinson's disease years before symptoms appear, revolutionizing early diagnosis and treatment ...
MedPage Today15h
Why Did a GLP-1 Receptor Agonist Fail This Parkinson's Trial?
The GLP-1 receptor agonist exenatide failed to meet its primary outcome in a phase III trial of Parkinson's disease patients.